急性大血管闭塞性缺血性卒中机械取栓后无复流现象：影像评估与治疗进展

doi:10.3969/j.issn.1673-5765.2025.12.016

摘要/Abstract

摘要： 机械取栓是急性大血管闭塞性缺血性卒中（acute ischemic stroke with large vessel occlusion，AIS-LVO）患者发病24 h内的标准治疗方案。然而，部分机械取栓后获得成功血管再通的患者仍存在缺血区域微循环灌注不足，即无复流现象（no-reflow phenomenon，NRP）。机械取栓后NRP可显著影响AIS-LVO患者的预后。目前，常规血管造影技术难以有效识别无复流区域，使得NRP的准确评估、预防及治疗仍面临挑战。本文结合国内外研究进展，系统综述AIS-LVO患者机械取栓后NRP的影像评估方式、预防与治疗策略，以期为临床诊疗实践提供参考。

文章导读： 本文聚焦急性大血管闭塞性缺血性卒中机械取栓后的无复流现象，系统探讨其影像评估标准与治疗新策略，以期为临床诊疗提供参考。

关键词: 卒中; 大血管闭塞; 机械取栓; 无复流现象

Abstract: Mechanical thrombectomy is the standard treatment for acute ischemic stroke with large vessel occlusion (AIS-LVO) within 24 hours of onset. However, some patients who achieve successful vascular recanalization after mechanical thrombectomy still suffer from insufficient microcirculatory perfusion in the ischemic area, a condition known as no-reflow phenomenon (NRP). NRP following mechanical thrombectomy can significantly compromise the prognosis of AIS-LVO patients. As current angiography cannot effectively identify no-reflow areas, accurate assessment, prevention, and treatment of NRP remain challenges. This article systematically reviews the imaging assessment methods, prevention and treatment strategies of NRP after mechanical thrombectomy in AIS-LVO patients based on recent domestic and international literature, with the aim of providing a reference for clinical decision-making.

Key words: Stroke; Large vessel occlusion; Mechanical thrombectomy; No-reflow phenomenon

中图分类号:

杨珂珂, 李晨威, 王小军, 冉江林, 冯志恒, 彭慧渊. 急性大血管闭塞性缺血性卒中机械取栓后无复流现象：影像评估与治疗进展[J]. 中国卒中杂志, 2025, 20(12): 1590-1597.

YANG Keke, LI Chenwei, WANG Xiaojun, RAN Jianglin, FENG Zhiheng, PENG Huiyuan. No-Reflow Phenomenon after Mechanical Thrombectomy for Acute Ischemic Stroke with Large Vessel Occlusion: Imaging Assessment and Treatment Progress[J]. Chinese Journal of Stroke, 2025, 20(12): 1590-1597.

参考文献

[1] MA Q F，LI R，WANG L J，et al. Temporal trend and attributable risk factors of stroke burden in China，1990-2019：an analysis for the global burden of disease study 2019[J/OL]. Lancet Public Health，2021，6（12）：e897-e906[2025-05-23]. https://doi.org/10.1016/S2468-2667(21)00228-0.
[2] SAINI V，GUADA L，YAVAGAL D R. Global epidemiology of stroke and access to acute ischemic stroke interventions[J/OL]. Neurology，2021，97（20 Suppl 2）：S6-S16[2025-05-23]. https://doi.org/10.1212/WNL.0000000000012781.
[3] GOYAL M，MENON B K，VAN ZWAM W H，et al. Endovascular thrombectomy after large-vessel ischaemic stroke：a meta-analysis of individual patient data from five randomised trials[J]. Lancet，2016，387（10029）：1723-1731.
[4] ALBERS G W，MARKS M P，KEMP S，et al. Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging[J]. N Engl J Med，2018，378（8）：708-718.
[5] NOGUEIRA R G，JADHAV A P，HAUSSEN D C，et al. Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct[J]. N Engl J Med，2018，378（1）：11-21.
[6] 中国卒中学会，中国卒中学会神经介入分会，中华预防医学会卒中预防与控制专业委员会介入学组. 急性缺血性卒中血管内治疗中国指南2023[J]. 中国卒中杂志，2023，18（6）：684-711.
Chinese Stroke Association，Chinese Interventional Neuroradiology Society，Intervention Group of Committee of Stroke Prevention and Control of Chinese Preventive Medicine Association. Chinese guidelines for endovascular therapy of acute ischemic stroke 2023[J]. Chin J Stroke，2023，18（6）：684-711.
[7] NIE X M，LENG X Y，MIAO Z R，et al. Clinically ineffective reperfusion after endovascular therapy in acute ischemic stroke[J]. Stroke，2023，54（3）：873-881.
[8] SPERRING C P，SAVAGE W M，ARGENZIANO M G，et al. No-reflow post-recanalization in acute ischemic stroke：mechanisms，measurements，and molecular markers[J]. Stroke，2023，54（9）：2472-2480.
[9] AMES A，3rd，WRIGHT R L，KOWADA M，et al. Cerebral ischemia. Ⅱ. The no-reflow phenomenon[J]. Am J Pathol，1968，52（2）：437-453.
[10] PANTEA-ROȘAN L R，BUNGAU S G，RADU A F，et al. A narrative review of the classical and modern diagnostic methods of the no-reflow phenomenon[J/OL]. Diagnostics（Basel），2022，12（4）：932[2025-05-23]. https://doi.org/10.3390/diagnostics12040932.
[11] JIA M L，JIN F Y，LI S J，et al. No-reflow after stroke reperfusion therapy：an emerging phenomenon to be explored[J/OL]. CNS Neurosci Ther，2024，30（2）：e14631[2025-05-23]. https://doi.org/10.1111/cns.14631.
[12] NG F C，COULTON B，CHAMBERS B，et al. Persistently elevated microvascular resistance postrecanalization[J]. Stroke，2018，49（10）：2512-2515.
[13] ZHAO W B，LIU R，YU W T，et al. Elevated pulsatility index is associated with poor functional outcome in stroke patients treated with thrombectomy：a retrospective cohort study[J]. CNS Neurosci Ther，2022，28（10）：1568-1575.
[14] KAN Y，LI S J，ZHANG B W，et al. No-reflow phenomenon following stroke recanalization therapy：clinical assessment advances：a narrative review[J]. Brain Circ，2023，9（4）：214-221.
[15] KOOPMAN M S，HOVING J W，TOLHUISEN M L，et al. Accuracy of four different CT perfusion thresholds for ischemic core volume and location estimation using intellispace portal[J/OL]. J Cardiovasc Dev Dis，2023，10（6）：239[2025-05-23]. https://doi.org/10.3390/jcdd10060239.
[16] VAGAL A，WINTERMARK M，NAEL K，et al. Automated CT perfusion imaging for acute ischemic stroke：pearls and pitfalls for real-world use[J]. Neurology，2019，93（20）：888-898.
[17] NG F C，CHURILOV L，YASSI N，et al. Prevalence and significance of impaired microvascular tissue reperfusion despite macrovascular angiographic reperfusion（no-reflow）[J/OL]. Neurology，2022，98（8）：e790-e801[2025-05-23]. https://doi.org/10.1212/WNL.0000000000013210.
[18] BAI X S，YU F，TIAN Q Y，et al. Clinical significance and influencing factors of microvascular tissue reperfusion after macrovascular recanalization[J]. Transl Stroke Res，2023，14（4）：446-454.
[19] MUTIMER C A，MUJANOVIC A，KAESMACHER J，et al. Comparison of perfusion imaging definitions of the no-reflow phenomenon after thrombectomy—what is the best perfusion imaging definition？[J]. Ann Neurol，2024，96（6）：1104-1114.
[20] JAAFAR N，ALSOP D C. Arterial spin labeling：key concepts and progress towards use as a clinical tool[J]. Magn Reson Med Sci，2024，23（3）：352-366.
[21] VAN DER KNAAP N，FRANX B A A，MAJOIE C B L M，et al. Implications of post-recanalization perfusion deficit after acute ischemic stroke：a scoping review of clinical and preclinical imaging studies[J]. Transl Stroke Res，2024，15（1）：179-194.
[22] TER SCHIPHORST A，CHARRON S，HASSEN W B，et al. Tissue no-reflow despite full recanalization following thrombectomy for anterior circulation stroke with proximal occlusion：a clinical study[J]. J Cereb Blood Flow Metab，2021，41（2）：253-266.
[23] NG F C. Prevalence and significance of impaired microvascular tissue reperfusion despite macrovascular angiographic reperfusion（no-reflow）[J/OL]. Neurology，2023，100（4）：218[2025-05-23]. https://doi.org/10.1212/WNL.0000000000206787.
[24] HERNANDEZ PETZSCHE M R，BÜRKLE J，HOFFMANN G，et al. Cerebral blood flow from arterial spin labeling as an imaging biomarker of outcome after endovascular therapy for ischemic stroke[J]. J Cereb Blood Flow Metab，2025，45（2）：219-232.
[25] SUN F Y，ZHOU J，CHEN X Y，et al. No-reflow after recanalization in ischemic stroke：from pathomechanisms to therapeutic strategies[J]. J Cereb Blood Flow Metab，2024，44（6）：857-880.
[26] DEBATISSE J，WATEAU O，CHO T H，et al. A non-human primate model of stroke reproducing endovascular thrombectomy and allowing long-term imaging and neurological read-outs[J]. J Cereb Blood Flow Metab，2021，41（4）：745-760.
[27] DEBATISSE J，CHALET L，EKER O F，et al. Quantitative imaging outperforms no-reflow in predicting functional outcomesin a translational stroke model[J/OL]. Neurotherapeutics，2025，22（2）：e00529[2025-05-23]. https://doi.org/10.1016/j.neurot.2025.e00529.
[28] SHABAN S，HUASEN B，HARIDAS A，et al. Digital subtraction angiography in cerebrovascular disease：current practice and perspectives on diagnosis，acute treatment and prognosis[J]. Acta Neurol Belg，2022，122（3）：763-780.
[29] AL-ALI F，TOMSICK T A，CONNORS J J，3rd，et al. Capillary index score in the interventional management of stroke trials Ⅰ and Ⅱ[J]. Stroke，2014，45（7）：1999-2003.
[30] NICOLINI E，IACOBUCCI M，DE MICHELE M，et al. No-reflow phenomenon in acute ischemic stroke：an angiographic evaluation[J]. Neurol Sci，2023，44（11）：3939-3948.
[31] PHAM T，TGAVALEKOS K，SASSAROLI A，et al. Quantitative measurements of cerebral blood flow with near-infrared spectroscopy[J]. Biomed Opt Express，2019，10（4）：2117-2134.
[32] ZHOU W J，KHOLIQOV O，ZHU J，et al. Functional interferometric diffusing wave spectroscopy of the human brain[J/OL]. Sci Adv，2021，7（20）：eabe0150[2025-05-23]. https://doi.org/10.1126/sciadv.abe0150.
[33] ITO U，HAKAMATA Y，KAWAKAMI E，et al. Temporary focal cerebral ischemia results in swollen astrocytic end-feet that compress microvessels and lead to focal cortical infarction[J]. J Cereb Blood Flow Metab，2011，31（1）：328-338.
[34] REZKALLA S H，STANKOWSKI R V，HANNA J，et al. Management of no-reflow phenomenon in the catheterization laboratory[J]. JACC Cardiovasc Interv，2017，10（3）：215-223.
[35] GRANFELDT A，HOLMBERG M J，NOLAN J P，et al. Temperature control after adult cardiac arrest：an updated systematic review and meta-analysis[J/OL]. Resuscitation，2023，191：109928[2025-05-23]. https://doi.org/10.1016/j.resuscitation.2023.109928.
[36] YOU J S，KIM J Y，YENARI M A. Therapeutic hypothermia for stroke：unique challenges at the bedside[J/OL]. Front Neurol，2022，13：951586[2025-05-23]. https://doi.org/10.3389/fneur.2022.951586.
[37] BASHTAWI Y，ALMUWAQQAT Z. Therapeutic hypothermia in STEMI[J/OL]. Cardiovasc Revasc Med，2021，29：77-84[2025-05-23]. https://doi.org/10.1016/j.carrev.2020.08.004.
[38] DAI W D，HALE S，KLONER R A. Delayed therapeutic hypothermia protects against the myocardial no-reflow phenomenon independently of myocardial infarct size in a rat ischemia/reperfusion model[J/OL]. Int J Cardiol，2017，236：400-404[2025-05-23]. https://doi.org/10.1016/j.ijcard.2017.01.079.
[39] EL AMKI M，WEGENER S. Improving cerebral blood flow after arterial recanalization：a novel therapeutic strategy in stroke[J/OL]. Int J Mol Sci，2017，18（12）：2669[2025-05-23]. https://doi.org/10.3390/ijms18122669.
[40] HASE Y，OKAMOTO Y，FUJITA Y，et al. Cilostazol，a phosphodiesterase inhibitor，prevents no-reflow and hemorrhage in mice with focal cerebral ischemia[J]. Exp Neurol，2012，233（1）：523-533.
[41] YANG M，HUO X C，MIAO Z R，et al. Platelet glycoprotein Ⅱb/Ⅲa receptor inhibitor tirofiban in acute ischemic stroke[J]. Drugs，2019，79（5）：515-529.
[42] DESILLES J P，LOYAU S，SYVANNARATH V，et al. Alteplase reduces downstream microvascular thrombosis and improves the benefit of large artery recanalization in stroke[J]. Stroke，2015，46（11）：3241-3248.
[43] RENÚ A，MILLÁN M，SAN ROMÁN L，et al. Effect of intra-arterial alteplase vs. placebo following successful thrombectomy on functional outcomes in patients with large vessel occlusion acute ischemic stroke：the CHOICE randomized clinical trial[J]. JAMA，2022，327（9）：826-835.
[44] Writing Committee for the PEARL Investigators，PEARL Investigators. Intra-arterial alteplase after successful endovascular reperfusion in acute stroke：the PEARL randomized clinical trial[J]. JAMA，2025，334（19）：1728-1739.
[45] EL AMKI M，GLÜCK C，BINDER N，et al. Neutrophils obstructing brain capillaries are a major cause of no-reflow in ischemic stroke[J/OL]. Cell Rep，2020，33（2）：108260[2025-05-23]. https://doi.org/10.1016/j.celrep.2020.108260.
[46] ZHANG M，PAN K Y，LIU Q P，et al. Growth differentiation factor 15 may protect the myocardium from no‑reflow by inhibiting the inflammatory‑like response that predominantly involves neutrophil infiltration[J]. Mol Med Rep，2016，13（1）：623-632.
[47] JIAO Q B，KE Q，LI W W，et al. Effect of inflammatory factor-induced cyclo-oxygenase expression on the development of reperfusion-related no-reflow phenomenon in acute myocardial infarction[J]. Clin Exp Pharmacol Physiol，2015，42（2）：162-170.
[48] KAUL S，METHNER C，CAO Z P，et al. Mechanisms of the“no-reflow”phenomenon after acute myocardial infarction：potential role of pericytes[J]. JACC Basic Transl Sci，2022，8（2）：204-220.
[49] SHROUDER J J，CALANDRA G M，FILSER S，et al. Continued dysfunction of capillary pericytes promotes no-reflow after experimental stroke in vivo[J]. Brain，2024，147（3）：1057-1074.
[50] PELLICCIA F，NICCOLI G，ZIMARINO M，et al. Pathophysiology and treatment of the no-reflow phenomenon in ST-segment elevation myocardial infarction：focus on low-dose fibrinolysis during primary percutaneous intervention[J/OL]. Rev Cardiovasc Med，2023，24（12）：365[2025-05-23]. https://doi.org/10.31083/j.rcm2412365.
[51] DARWISH A，FRERE A F，ABDELSAMIE M，et al. Intracoronary epinephrine versus adenosine in the management of refractory no-reflow phenomenon：a single-center retrospective cohort study[J]. Ann Saudi Med，2022，42（2）：75-82.